Peptides
Peptides can accelerate tissue healing by promoting cellular repair and reducing inflammation, aiding recovery from injuries and supporting physical performance under medical guidance. Others can boost growth hormone production and mitochondrial function, enhancing muscle growth and metabolism.
BPC-157
BPC-157 is recognized for its robust regenerative effects. It promotes tissue repair by enhancing blood vessel formation, reducing inflammation, and supporting collagen synthesis. It is commonly used for muscle, tendon, and ligament recovery.
Thymosin Beta 500
TB-500 promotes tissue repair by enhancing cell migration, blood vessel formation, and actin regulation, crucial for healing processes. TB-500 is frequently used to aid recovery from muscle, tendon, and ligament injuries, while also reducing inflammation and improving tissue flexibility.
GHK-Cu
GHK-Cu, a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine copper complex), modulates tissue remodeling by promoting collagen and elastin synthesis, reducing inflammation, and enhancing antioxidant activity to support cellular repair and rejuvenation.
Sermorelin
Sermorelin mimics the body's own signaling to stimulate the release of growth hormone (GH) directly from the pituitary gland. Benefits include accelerated tissue recovery, improved metabolic function with enhanced fat loss and lean muscle preservation, and anti-aging effects such as better skin elasticity and increased energy levels.
CJC-1295/Ipamorelin
CJC-1295, a growth hormone-releasing hormone (GHRH) analog, stimulates sustained release of GH, while Ipamorelin, a selective ghrelin receptor agonist, induces a pulse of GH release. They are used together for sustained and quick release of GH
Tesamorelin
Tesamorelin mimics the body's signal to release growth hormone (GH) from the pituitary gland, with a particular affinity for targeting visceral fat accumulation. This helps reduce excess abdominal fat, improve lipid profiles, and enhance overall metabolic health. Tesamorelin is FDA-approved for visceral fat reduction. It is noted for its relatively low risk of side effects compared to broader GH therapies.
Tirzepatide
Tirzepatide is a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It promotes substantial weight loss and metabolic improvement by reducing appetite, slowing gastric emptying, stimulating glucose-dependent insulin secretion, suppressing glucagon, and enhancing fat oxidation and satiety. It is FDA-approved for chronic weight management.
Mots-C
Retatrutide
MOTS-c is a mitochondrial-derived peptide that mimics exercise-induced signaling to enhance metabolic homeostasis. This helps improve insulin sensitivity, promote glucose uptake in skeletal muscle, enhance fat oxidation, reduce insulin resistance, and support overall metabolic health, with potential benefits for obesity, diabetes, aging, and physical performance.
Retatrutide is an investigational triple agonist of the GIP, GLP-1, and glucagon receptors. It combines the appetite-suppressing and insulin-sensitizing effects of dual incretin agonism with glucagon receptor activation to boost energy expenditure, promote lipolysis, and enhance fat utilization. It may lead to improvements in glycemic control, liver fat reduction, and cardiometabolic parameters. It offers superior fat loss compared to dual agonists.